UTHSCSA Pediatric Resident Curriculum for the PICU ASTHMA IN THE PICU.

Slides:



Advertisements
Similar presentations
Bronchodilators and Other Respiratory Agents
Advertisements

Role of anticholinergic therapy in COPD Adil Al Sulami Medical Resident KAUH.
STATUS ASTHMATICUS Sigrid Hahn, MD Andy Jagoda, MD, FACEP Department of Emergency Medicine Mount Sinai School of Medicine New York, New York.
Respiratory/Pulmonary Emergencies
Cases from Aug 2014 Cases from Aug 2014 Ryan Padrez & Patrick Peebles 9/10/14.
Educational Resources
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 32 Bronchodilator Drugs and the Treatment of Asthma.
Asthma. Asthma As a chronic inflammatory disease of the airway that causes airway hyperresponsiveness, mucosal odema, & mucus production. The inflammation.
AsthmaAsthma is a condition characterized by paroxysmal narrowing of the bronchial airways due to inflammation of the bronchi and contraction of the bronchial.
MECHANICS OF BREATHING Lecture-2 Dr. Zahoor Ali Shaikh 1.
Work of Breathing Components 1. Compliance work65% (stretching lungs & chest wall) 2. Airways resistance work30% 3. Moving tissues  5% Normally
Take a Deep Breath Asthma in Children Michael W. Peterson, M.D. Professor and Chief of Medicine UCSF Fresno.
Meconium Aspiration Syndrome Edited May  PO 2 L --> R ductus arteriosus shunt Ventilation Remove Placenta Ductus Venosus Closes  Systemic Vascular.
ASTHMA AND COPD By Jess Laidlaw. Overview 1)Asthma 2)COPD 3)Comparison.
Asthma What is Asthma ? V1.0 1997 Merck & ..
Disorders of the respiratory system. Respiratory structures such as the airways, alveoli and pleural membranes may all be affected by various disease.
Drugs For Treating Asthma
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
IMPACTS OF CRITERIA AIR POLLUTANTS ON THE RESPIRATORY HEALTH OF CHILDREN John R. Balmes, MD UCSF.
Chronic Obstructive Pulmonary Disease and Asthma: All That Wheezes? Clifford Courville, MD Pulmonary, Allergy, and Critical Care.
Immunology of Asthma Immunology Unit Department of Pathology King Saud University.
To Breathe or not to Breathe… The Asthmatic’s Struggle Nicole J. Wagner, BSN, RN-BC Alverno College Spring 2012 MSN 621.
Asthma is a chronic inflammatory disease of the airways, characterized by coughing, wheezing, chest tightness, and difficult breathing.
Immunology of Asthma Dr. Hend Alotaibi Assistant Professor & Consultant College of Medicine, King Saud University Dermatology Department /KKUH
Pediatric Asthma Teaching at Denver Health Erin Hoffman Marsha Davis Laura Sawicky Erin Blakeslee.
Asthma By: Emily Ngo. Asthma Background Asthma is a chronic disease that affects up to 150 million people in the world Asthma is an inflammatory disease.
Pathophysiology of asthma and chronic obstructive pulmonary disease M. Tatár.
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Habib GHEDIRA, MD, Prof. Medical Faculty of Tunis
Childhood Asthma A triad of atopic eczema, allergic rhinitis and asthma is called atopy.[53] The strongest risk factor for developing asthma is a history.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Case No. 12 SH, 25 years old with a history of asthma since childhood presented to the OPD clinic with complaints of worsening dyspnea and wheezing. He.
Hypersensitivity refers to an inappropriate or undesirable immune response ( damaging immunological reactions to extrinsic antigens) Hypersensitivity.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
 Definition  Asthma is a chronic inflammatory disorder of the lung airways, characterised by reversible airway obstruction, airway hyper-responsiveness,
Anticholinergics in COPD presented by: Soha Ragab Moselhy group 2.
1 Asthma October 30, Weiss, Gergen, & Hodgson (1992)2 Pediatric Statistics Prevalence increasing School absences Estimated as more than 10 million.
Bronchodilators Lilley Pharmacology Text: Chapter 35
1 Respiratory Emergencies. 2 Objectives Differentiate between the categories of respiratory dysfunction Describe the assessment of a child with respiratory.
Asthma Diagnosis: Anatomy and Pathophysiology of Asthma Karen Meyerson, MSN, RN, FNP-C, AE-C Asthma Network of West Michigan April 21, 2009 Acknowledgements:
Pulmonary Pathophysiology III Iain MacLeod, Ph.D Iain MacLeod 16 November 2009.
Oxygen Debt: Definition:
Treatments for Asthma Ghazaleh Ebrahimnejadalamaki, Gea Panić, Natali Surkic, Romina Isip [1] PHM142 Fall 2015 Coordinator: Dr. Jeffrey Henderson Instructor:
Advanced Asthma Training Course Mechanisms Of Asthma Part II Dr.Hadeel A.K AlOtair ABIM,MRCP(UK),FCCP Assisstant professor of Medicine consultant pulmonologist.
OBSTRUCTIVE AIRWAY DISEASE
Bronchial asthma By Dr. Abdelaty Shawky Assistant professor of pathology.
Update Presented by: Katy Zahner BSN, RN, CCRN Georgetown University Nurse Educator Student.
Bronchodilators and Other Respiratory Agents
Respiratory System Anatomy. Asthma most common cause of chronic illness in children unusually sensitive and irritable conducting passageways.
Advances in Pediatric Asthma Care Keyvan Rafei, MD, MBA Division Head, Pediatric Emergency Medicine Chairman, Pediatric Asthma Program.
ASTHMA. INTRODUCTION Asthma is a disorder of the respiratory system that leads to episodic difficulty in breathing. It is a chronic inflammatory disorder.
Atelectasis.
β2 Agonists Albuterol and other inhaled short-acting selective β2 agonists are indicated for treatment of intermittent episodes of bronchospasm and are.
Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Ignatavicius Chapter 32 Care of Patients with Noninfectious Lower Respiratory.
Asthma 1 د. ميريانا البيضة. DIAGNOSIS 2 3 Definition of asthma.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &
Management of Severe Asthma and COPD
Immunology Unit Department of Pathology King Saud University
Asthma Case Study – Module 9.
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
Disorders of the respiratory system
APPROACH TO A PATIENT WITH ACUTE SEVERE ASTHMA
Bronchial Asthma.
ACUTE INTERVENTION IN < 10 SLIDES! 1/25/2017
Drugs Affecting the Respiratory System
Asthma.
Asthma.
Immunology Unit Department of Pathology King Saud University
Immunology Unit Department of Pathology King Saud University
Presentation transcript:

UTHSCSA Pediatric Resident Curriculum for the PICU ASTHMA IN THE PICU

UTHSCSA Pediatric Resident Curriculum for the PICU Epidemiology million Americans million Americans Nearly 5 million children Nearly 5 million children 5,000 people (mostly adults) die each year 5,000 people (mostly adults) die each year Incidence, hospitalization rate, and death rate is increasing each year. Incidence, hospitalization rate, and death rate is increasing each year year-olds are at higher risk of dying from asthma than are 0-4 year olds year-olds are at higher risk of dying from asthma than are 0-4 year olds. Prior asthma episode requiring mechanical ventilation is strong predictor of subsequent asthma death. Prior asthma episode requiring mechanical ventilation is strong predictor of subsequent asthma death.

UTHSCSA Pediatric Resident Curriculum for the PICU Pathogenesis Asthma is a chronic inflammatory disease of the airways. Asthma is a chronic inflammatory disease of the airways. Asthma is characterized by bronchospasm, airway edema, and mucus production Asthma is characterized by bronchospasm, airway edema, and mucus production Asthma has several components: Asthma has several components: – Cellular – Cytokines – Neurologic

UTHSCSA Pediatric Resident Curriculum for the PICU Pathophysiology Asthma is an obstructive pulmonary disease. Asthma is an obstructive pulmonary disease. Air-trapping and over-expansion of alveoli is a hallmark of asthma. Air-trapping and over-expansion of alveoli is a hallmark of asthma. Air-trapping may lead to air-leak, which can be fatal. Air-trapping may lead to air-leak, which can be fatal. In addition, active expiration may be required to return the lung volume to FRC. In addition, active expiration may be required to return the lung volume to FRC. Muscles of expiration are not designed for active expiration and quickly become fatigued, leading to respiratory failure and death. Muscles of expiration are not designed for active expiration and quickly become fatigued, leading to respiratory failure and death.

UTHSCSA Pediatric Resident Curriculum for the PICU Triggers Numerous things can trigger asthma attacks: Numerous things can trigger asthma attacks: – Allergens – Exercise – Stress – Viruses – Medicines – Noxious stimuli

UTHSCSA Pediatric Resident Curriculum for the PICU Cellular component Numerous cells involved: Numerous cells involved: – Mast cells – Eosinophils – Lymphocytes (TH-2 cells) – Neutrophils – Epithelial cells

UTHSCSA Pediatric Resident Curriculum for the PICU Cytokines Numerous soluble products of the cells exacerbate asthma: Numerous soluble products of the cells exacerbate asthma: – Interleukins – Bradykinins – Histamine

UTHSCSA Pediatric Resident Curriculum for the PICU Neurologic Parasympathetic Parasympathetic – Stimulation via the vagus leads to airway constriction. Sympathetic Sympathetic – Plays little role in humans since only pulmonary vasculature, not airway smooth muscle, is innervated Non-adrenergic non-cholinergic (NANC) Non-adrenergic non-cholinergic (NANC) – Role in humans not determined. – Vasoactive intestinal polypeptide, Substance P, NO

UTHSCSA Pediatric Resident Curriculum for the PICU Receptors Beta Beta – 3 subtypes –  2 is common in airway smooth muscle – Activation leads to increase in cAMP Alpha: little role Alpha: little role Cholinergic Cholinergic – Muscarinic receptors: M 2 receptor inhibits acetylcholine release, leading to bronchodilation. M 2 receptor inhibits acetylcholine release, leading to bronchodilation. M 3 receptor cause bronchoconstriction M 3 receptor cause bronchoconstriction

UTHSCSA Pediatric Resident Curriculum for the PICU Physical Exam Respiratory Rate Respiratory Rate Work-of-Breathing Work-of-Breathing Breath Sounds Breath Sounds Inspiratory:Expiratory Phase Inspiratory:Expiratory Phase Cyanosis Cyanosis Mental status Mental status

UTHSCSA Pediatric Resident Curriculum for the PICU Respiratory rate Normal Normal – Infants: <40 – Toddlers: <30 – Preschoolers: <30 – Elementary School: low 20s – High school: upper teens

UTHSCSA Pediatric Resident Curriculum for the PICU Work-of-breathing Nasal Flaring Nasal Flaring Retractions Retractions – Supraclavicular – Intercostal – Substernal Paradoxical Breathing Paradoxical Breathing

UTHSCSA Pediatric Resident Curriculum for the PICU Breath sounds Lung Fields Lung Fields Air flow Air flow – Good, fair, poor Expiratory Wheeze Expiratory Wheeze – Polysyllabic vs. Monosyllabic Inspiratory Wheeze Inspiratory Wheeze – Common, even in non-diseased states

UTHSCSA Pediatric Resident Curriculum for the PICU Phases Normally, expiratory phase is the same as, or shorter than the inspiratory phase. Normally, expiratory phase is the same as, or shorter than the inspiratory phase. In asthma, the expiratory phase is prolonged as airway collapse and air-trapping occur. In asthma, the expiratory phase is prolonged as airway collapse and air-trapping occur. Intrathoracic pressure becomes higher than the large airway pressure, leading to collapse of the airways. Intrathoracic pressure becomes higher than the large airway pressure, leading to collapse of the airways. Airway edema, bronchospasm, and mucus impede air movement. Airway edema, bronchospasm, and mucus impede air movement.

UTHSCSA Pediatric Resident Curriculum for the PICU Cyanosis Need 5gm/dl of unoxygenated hemoglobin before cyanosis present Need 5gm/dl of unoxygenated hemoglobin before cyanosis present Cyanosis will be more pronounced in children with high hematocrits: dehydrated, cyanotic heart disease Cyanosis will be more pronounced in children with high hematocrits: dehydrated, cyanotic heart disease Cyanosis can be a sign of impending respiratory failure….or not. Cyanosis can be a sign of impending respiratory failure….or not.

UTHSCSA Pediatric Resident Curriculum for the PICU Mental Status Hypoxia and hypercarbia can lead to mental status changes. Hypoxia and hypercarbia can lead to mental status changes. Fatigue can, too. Fatigue can, too. Improvement can, too. Improvement can, too. Watch for agitation, delirium, unresponsiveness, especially to pain. Watch for agitation, delirium, unresponsiveness, especially to pain.

UTHSCSA Pediatric Resident Curriculum for the PICU Laboratory tests PEFR PEFR PFTs PFTs Asthma Scores Asthma Scores IgE IgE Allergy tests Allergy tests Blood gas Blood gas CXR CXR

UTHSCSA Pediatric Resident Curriculum for the PICU Treatments Oxygen Oxygen Steroids Steroids – Inhaled – Systemic Beta Agonists Beta Agonists – Short-acting – Long-acting Anticholinergics Anticholinergics Leukotriene Inhibitors Leukotriene Inhibitors Methylxanthines Methylxanthines Magnesium Magnesium

UTHSCSA Pediatric Resident Curriculum for the PICU Oxygen/Fluid Ventilation/perfusion mismatch can be quite high Ventilation/perfusion mismatch can be quite high Oxygen lends to patient comfort Oxygen lends to patient comfort In absence of chronic pulmonary disease, i. e., CO 2 retention, supplemental oxygen will not suppress the respiratory drive In absence of chronic pulmonary disease, i. e., CO 2 retention, supplemental oxygen will not suppress the respiratory drive Most patients with asthma are dehydrated (increased insensible losses, decreased intake) Most patients with asthma are dehydrated (increased insensible losses, decreased intake) Overhydration can exacerbate pulmonary edema. Overhydration can exacerbate pulmonary edema. Watch for SIADH. Watch for SIADH.

UTHSCSA Pediatric Resident Curriculum for the PICU Steroids Only drug that addresses the underlying pathophysiology Only drug that addresses the underlying pathophysiology Solumedrol Solumedrol – 2mg/kg/day divided q6hr – Max is 60mg/day “kids,” 180mg/day “adults” – IV Prednisone or Prednisolone Prednisone or Prednisolone – Oral

UTHSCSA Pediatric Resident Curriculum for the PICU Steroids No difference between IV and po No difference between IV and po Usually give IV in severe attack because of nausea and high respiratory rate increases risk of aspiration Usually give IV in severe attack because of nausea and high respiratory rate increases risk of aspiration 5 day course of therapy won’t suppress adrenal system 5 day course of therapy won’t suppress adrenal system Start to work in 8-12 hours Start to work in 8-12 hours

UTHSCSA Pediatric Resident Curriculum for the PICU Steroids Complications Complications – Hypertension – Hyperglycemia – Hypokalemia – Gastritis

UTHSCSA Pediatric Resident Curriculum for the PICU Inhaled Steroids For long term control For long term control Fewer side effects than systemic steroids, but may be associated with long-term growth suppression. Fewer side effects than systemic steroids, but may be associated with long-term growth suppression. – Beclomethasone – Budenoside – Flunisolide – Fluticasone – Triamcinolone

UTHSCSA Pediatric Resident Curriculum for the PICU Beta-agonists Work via the  2 receptor to bronchodilate Work via the  2 receptor to bronchodilate Albuterol Albuterol Terbutaline Terbutaline Can cause hypokalemia, tremors, nausea, vomiting, tachycardia Can cause hypokalemia, tremors, nausea, vomiting, tachycardia

UTHSCSA Pediatric Resident Curriculum for the PICU Beta-agonists Give via MDI or nebs Give via MDI or nebs Dose: Dose: – Depends upon size, severity of disease, and delivery device. Titrate to heart rate and response – Usual neb dose: <10kg: 2.5mg/hr <10kg: 2.5mg/hr 10-20kg: 5mg/hr 10-20kg: 5mg/hr 20-30kg: 10mg/hr 20-30kg: 10mg/hr >30kg: 15mh/hr >30kg: 15mh/hr

UTHSCSA Pediatric Resident Curriculum for the PICU Anti-cholinergics Atropine and atrovent Atropine and atrovent Bronchodilate and decrease mucus production Bronchodilate and decrease mucus production Additive effect with beta-agonists. Additive effect with beta-agonists. Use for beta-blocker induced asthma Use for beta-blocker induced asthma Complications include drying of the airways and rarely, increased wheezing Complications include drying of the airways and rarely, increased wheezing Atrovent dose: mcg/dose up to q 20min, usually q2-4hrs. Atrovent dose: mcg/dose up to q 20min, usually q2-4hrs.

UTHSCSA Pediatric Resident Curriculum for the PICU Leukotriene inhibitors Block the actions of leukotrienes Block the actions of leukotrienes Zafirlukast and zileuton Zafirlukast and zileuton Used for long-term control Used for long-term control Little use in acute attacks Little use in acute attacks May be as effective as inhaled steroids May be as effective as inhaled steroids Rare side effects (liver damage) Rare side effects (liver damage)

UTHSCSA Pediatric Resident Curriculum for the PICU Methylxanthines Theophylline and aminophylline Theophylline and aminophylline Actions are several: Actions are several: – Phosphodiesterase inhibitor (increases cAMP) – Stimulates catecholamine release – Diueresis – Augments diaphragm contractility – Prostoglandin antagonist May be of little benefit in routine use for acute asthma May be of little benefit in routine use for acute asthma High risk of side effects: N/V, tachycardia, agitation, cardiac arrythmias, hypotension, seizures, death High risk of side effects: N/V, tachycardia, agitation, cardiac arrythmias, hypotension, seizures, death

UTHSCSA Pediatric Resident Curriculum for the PICU Magnesium Mechanism unclear, but may be a direct bronchodilator through blocking calcium Mechanism unclear, but may be a direct bronchodilator through blocking calcium Raising the Mg levels up to 2-4 mg/dL significantly improved expiratory air flow in adults Raising the Mg levels up to 2-4 mg/dL significantly improved expiratory air flow in adults One study in children showed that MgSO 4 25mg/kg over 20 minutes significantly improved PFTs, but did not change hospitalization rate or length of stay in the ED. One study in children showed that MgSO 4 25mg/kg over 20 minutes significantly improved PFTs, but did not change hospitalization rate or length of stay in the ED. Relatively safe. Levels >12 can cause weakness, areflexia, respiratory depression, and cardiac arrhythmias Relatively safe. Levels >12 can cause weakness, areflexia, respiratory depression, and cardiac arrhythmias

UTHSCSA Pediatric Resident Curriculum for the PICU Weaning protocol Patients selected by attending/resident Patients selected by attending/resident Physician writes order Physician writes order Physician writes initial dose and frequency of bronchodilator Physician writes initial dose and frequency of bronchodilator Respiratory therapist evaluates patient and changes therapy in accordance with protocol Respiratory therapist evaluates patient and changes therapy in accordance with protocol

UTHSCSA Pediatric Resident Curriculum for the PICU Treatment levels Level 1: Continuous albuterol at > 0.6 mg/kg/hr Level 1: Continuous albuterol at > 0.6 mg/kg/hr Level 2: Continuous albuterol at 0.3 mg/kg/hr Level 2: Continuous albuterol at 0.3 mg/kg/hr – (Max 15 mg/hr) Level 3: Continuous albuterol at 0.15mg/kg/hr Level 3: Continuous albuterol at 0.15mg/kg/hr Level 4: Albuterol at about 0.3mg/kg q2hours Level 4: Albuterol at about 0.3mg/kg q2hours – Infants <5kg use 1.0 mg – Infants kg use 2.5 mg – Children kg use 5.0 mg – Children > 20 kg round to closest multiple of 2.5 mg (2.5, 5.0, 7.5, etc)

UTHSCSA Pediatric Resident Curriculum for the PICU Treatment levels Level 5 : Albuterol q3 hours at same dose as level 4 Level 5 : Albuterol q3 hours at same dose as level 4 – When the patient has been stable on q3 hour treatments for 2 treatment intervals, therapist is to call the physician to evaluate for possible transfer out of the PICU (anytime of day or night). – If the patient is also receiving intermittent Atrovent nebulizations q2 or q4 hours, the therapist should make these q3 to coincide with the albuterol treatments. Level 6 : Albuterol q4 hours, same dose as level 4 and 5 Level 6 : Albuterol q4 hours, same dose as level 4 and 5 Level 7 : Albuterol q4 hours at about 0.15mg/kg if dose for previous levels is above 2.5 mg Level 7 : Albuterol q4 hours at about 0.15mg/kg if dose for previous levels is above 2.5 mg Level 8 : Albuterol q6 hours, same dose Level 8 : Albuterol q6 hours, same dose

UTHSCSA Pediatric Resident Curriculum for the PICU Acute Asthma Score Modified from Woods, et al, AJDC, 1972

UTHSCSA Pediatric Resident Curriculum for the PICU Weaning criteria A. Respiratory therapist has evaluated patient and feels the patient is not acutely distressed, AND B. The asthma score is less than or equal to 3, AND C. If the patient is over 6 years and cooperative, the peak flows are > 70% of predicted, AND D. The patient must be stable at these criteria for 3 hours or for two treatment intervals, whichever is longer.

UTHSCSA Pediatric Resident Curriculum for the PICU Failure criteria A.The therapist (or nurse) judges the patient to be in increased distress, but not severe distress. OR B. The asthma score increases to greater than 3 but less than 5. OR C. The PEFR drops to less than 70% predicted but greater than 50% of predicted.

UTHSCSA Pediatric Resident Curriculum for the PICU Deterioration criteria A. The respiratory therapist (or nurse) judges the patient has developed severe distress. OR B. The asthma score increases to more than or equal to 5. OR C. The PEFR drops to less than 50% of predicted.